Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 6,595 | 7,360 | $897,321 | $261,388 |
| 2022 | 31 | 6,499 | 7,774 | $859,976 | $275,560 |
| 2021 | 29 | 7,786 | 9,211 | $997,297 | $333,590 |
| 2020 | 31 | 8,594 | 11,228 | $1.1M | $358,383 |
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 57 | 61 | $509.35 | $498.98 | 98.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 39 | 50 | $1,000 | $423.93 | 42.4% |
| 88175 | Pap test, automated thin layer preparation; automated system and manual rescreening | Office | 2022 | 2,065 | 2,090 | $215,297 | $54,801 | 25.5% |
| 81513 | Measurement of rna of bacteria in vaginal fluid specimen | Office | 2022 | 263 | 294 | $52,920 | $41,273 | 78.0% |
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | Office | 2022 | 904 | 918 | $119,340 | $31,802 | 26.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 337 | 550 | $152,730 | $28,241 | 18.5% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 342 | 681 | $47,670 | $23,577 | 49.5% |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | Office | 2022 | 702 | 702 | $72,306 | $18,363 | 25.4% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 147 | 512 | $35,840 | $17,750 | 49.5% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2022 | 188 | 210 | $14,700 | $7,290 | 49.6% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2022 | 132 | 162 | $11,340 | $5,613 | 49.5% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2022 | 130 | 156 | $10,920 | $5,408 | 49.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2022 | 17 | 83 | $20,750 | $5,369 | 25.9% |
| 87491 | Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | Office | 2022 | 139 | 154 | $10,780 | $5,314 | 49.3% |
| 87591 | Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | Office | 2022 | 134 | 149 | $10,430 | $5,142 | 49.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 47 | 55 | $13,750 | $4,079 | 29.7% |
| 88141 | Pap test | Office | 2022 | 239 | 245 | $18,865 | $3,731 | 19.8% |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | Office | 2022 | 96 | 96 | $12,480 | $3,333 | 26.7% |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | Office | 2022 | 61 | 74 | $5,180 | $2,567 | 49.6% |
| 88142 | Pap test, manual screening | Office | 2022 | 96 | 97 | $5,723 | $1,941 | 33.9% |
| 87529 | Detection test by nucleic acid for herpes simplex virus, amplified probe technique | Office | 2022 | 24 | 48 | $3,360 | $1,665 | 49.6% |
| 87480 | Detection test for candida species (yeast), direct probe technique | Office | 2022 | 59 | 63 | $4,851 | $1,228 | 25.3% |
| 87510 | Detection test for gardnerella vaginalis (bacteria), direct probe technique | Office | 2022 | 59 | 63 | $4,851 | $1,228 | 25.3% |
| 87660 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique | Office | 2022 | 52 | 54 | $4,158 | $1,032 | 24.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 11 | 13 | $3,042 | $1,016 | 33.4% |
About Dr. Bradly Clark, MD
Dr. Bradly Clark, MD is a Anatomic Pathology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023098928.
As a Medicare-enrolled provider, Clark has provided services to 29,474 Medicare beneficiaries, totaling 35,573 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology
- Location Memphis, TN
- Active Since 01/18/2006
- Last Updated 05/12/2016
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1023098928
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Memphis
Dr. James Downing, Md, MD
Anatomic Pathology — Payments: $4,298
Jeffery Klco, M.d, M.D
Anatomic Pathology — Payments: $2,368
Dr. Karin Berg, Md, MD
Anatomic Pathology — Payments: $470.85
Dr. Marianna Szabo, Md, MD
Anatomic Pathology — Payments: $314.17
Dr. Xianfeng Zhao, M.d, M.D
Anatomic Pathology — Payments: $229.16
Jason Chiang, Md, Phd, MD, PHD
Anatomic Pathology — Payments: $24.77